Skip to content
Tuesday, March 03, 2026

  • About the Jewish Review
  • Advertise
  • Contact Us
  • Home
  • Opt-out preferences
  • Terms of Use

Tag: Ranking

Teva back in top pharmaceutical rankings

April 16, 2024April 16, 2024David Rutman

After years of financial problems, downsizing, and dismissals, Israel’s multinational Teva Pharmaceutical Industries Ltd. has been named No. 19 among the top 20 best-earning pharmaceutical companies in the world. In 2022, Teva had revenues of $14.9 billion, which rose to $15.8b. last year. It has long specialized in generic drugs, but it has had some […]

Continue Reading

Recent Posts

  • Berlin groups received $3M to fight antisemitism. What happened to that money? March 3, 2026
  • A bris between missile alerts was the ultimate show of Jewish defiance against a tyrannical enemy March 3, 2026
  • Did Israel force Trump into war with Iran? After Marco Rubio suggests so, Israel’s critics erupt. March 3, 2026
  • Iran, Israel and Hitler’s gun are all on the ballot in key primaries in Texas and NC on Tuesday March 2, 2026
  • Speaking Up Is an Obligation, Not a Choice March 2, 2026
  • Death of Iranian leader just before Purim revives Book of Esther parallels March 2, 2026

Categories

  • Business
  • Culture
  • Israel
  • Local
  • Opinion
  • Science and Health
  • Uncategorized
  • World News
News Vibrant | Theme: News Vibrant by CodeVibrant.